Radial Approach–It’s Time for Options

Transradial access for percutaneous coronary interventions is a growing trend that is helping to shape Merit’s radial approach product line. “Transradial PCI has grown from 1.3% of PCI in the US in 2007 to 4.5% in 2009 and may now be over 10%,” reports Dr. Jennifer Tremmel (Stanford University, CA) who believes “this rate may soon surpass the 29% seen outside the US.”

Merit is perfectly positioned to maximize the radial access opportunity by offering several new product options in a comprehensive radial approach product line, including the Finale® radial compression device and the Prelude® sheath introducer. These products complement Merit’s broad offering of ancillary products used in interventional cardiology and provide additional product selection options for clinicians who prefer the radial approach.

As percutaneous transradial access procedures become more popular among interventionalists all over the world, the need for adequate training in the technique will become increasingly important. In response to this need, Merit is also in the process of implementing radial access training programs. Due to our expanded radial product offering and the radial access training programs, Merit is already experiencing rapid sales growth.

Larry Tolman
Merit Medical Systems, Inc.

Merit Medical Supports Local Initiative to Help Those with Multiple Sclerosis

Merit employees have joined together to support “Accept the Challenge” Utah Bike MS 2011 a local event to help raise money for programs and services that help people with MS. It is gratifying to be a part of this great project and to feel like we are making a difference for this worthy cause.

Larry Tolman
Merit Medical Systems, Inc.

European Association of Percutaneous Cardiovascular Interventions (EuroPCR)

Merit is preparing to attend one of the largest cardiology trade shows in the world–the EuroPCR that will be held in Paris, May 17-20, 2011. With over 9000 attendees participating in almost 400 sessions over 4 days, there will be plenty of opportunity for Merit to make a positive impression.

We’ll have a strong presence at the show and hope to generate enthusiasm for our products and capture the interest of many new potential customers by featuring several of our recently released products, including the ASAP® aspiration catheter, the Merit Laureate® hydrophilic guide wire, the TRAM™ and TRAM-P™ manifold and transducer, the Prelude® sheath introducers, the Finale® radial compression device, and the EN Snare® endovascular snare system. EuroPCR is just one of many prestigious trade shows Merit will be attending this year.

Larry Tolman
Merit Medical Systems, Inc.

Global Embolization Symposium & Technologies Trade Show

Merit recently attended the GEST (Global Embolization Symposium & Technologies) trade show in Paris, France. With the acquisition of BioSphere, the company is now a comprehensive resource for peripheral embolization technologies. Many highly qualified leads were generated at the meeting and there was a lot of interest in our products.

Our direct sales representatives in the United States and Europe, along with our global dealer network in other areas of the world, support a broad offering of products used for embolization, including embolic microspheres (Embosphere®, EmboGold®, HepaSphere™ and QuadraSphere®), Merit Maestro® and EmboCath® Plus Microcatheters, and a broad offering of specialty guide wires used for embolization procedures. These devices, as well as the company’s comprehensive portfolio of thousands of ancillary supporting products like sheath introducers, color coded syringes, needles and mini access kits, offer the dependability, predictability and consistency that have become the standard of Merit Medical.

This trade show provided a wonderful opportunity to meet and capture the interest of key physicians throughout the world.

Larry Tolman
Merit Medical Systems, Inc.